Correlation Between Adial Pharmaceuticals and PsyBio Therapeutics

Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adial Pharmaceuticals and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Adial Pharmaceuticals and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and PsyBio Therapeutics.

Diversification Opportunities for Adial Pharmaceuticals and PsyBio Therapeutics

-0.14

Correlation Coefficient

Adial Pharmaceuticals  PsyBio Therapeutics

Good diversification

The 3 months correlation between Adial and PsyBio is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between Adial Pharmaceuticals and PsyBio Therapeutics

Given the investment horizon of 90 days Adial Pharmaceuticals is expected to generate 206.58 times less return on investment than PsyBio Therapeutics. But when comparing it to its historical volatility, Adial Pharmaceuticals is 31.6 times less risky than PsyBio Therapeutics. It trades about 0.02 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.01  in PsyBio Therapeutics Corp on September 17, 2024 and sell it today you would earn a total of  0.00  from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Adial Pharmaceuticals  vs.  PsyBio Therapeutics Corp

Adial Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Adial Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent forward indicators, Adial Pharmaceuticals is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

PsyBio Therapeutics Corp

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Adial Pharmaceuticals and PsyBio Therapeutics

The main advantage of trading using opposite Adial Pharmaceuticals and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.

The idea behind Adial Pharmaceuticals and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.